VERO

Venus Concept Inc. [VERO] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

VERO Stock Summary

Top 10 Correlated Stocks

VERO


In the News

10:31 20 Feb 2024 VERO

Venus Concept (VERO) Expands Global Reach With New Partnerships

Venus Concept (VERO) expects its deals to fetch continued success in both the United Kingdom and India.

06:57 20 Feb 2024 VERO

Venus Concept Inc. (VERO) Q3 2023 Earnings Call Transcript

Venus Concept Inc. (NASDAQ:VERO ) Q3 2023 Earnings Conference Call November 14, 2023 5:00 PM ET Company Participants Rajiv De Silva - Chief Executive Officer Hemanth Varghese - President & Chief Operating Officer Domenic Della Penna - Chief Financial Officer Conference Call Participants Jeff Cohen - Ladenburg Thalmann Sam Eiber - BTIG Operator Please standby. Good day, ladies and gentlemen.

04:05 20 Feb 2024 VERO

Venus Concept to Release Third Quarter of Fiscal Year 2023 Financial Results on November 14, 2023

TORONTO, Oct. 09, 2023 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that third quarter of fiscal year 2023 financial results will be released after the market closes on Tuesday, November 14, 2023.

10:44 20 Feb 2024 VERO

Venus Concept Inc. (VERO) Q2 2023 Earnings Call Transcript

Venus Concept Inc. (NASDAQ:VERO ) Q2 2023 Earnings Conference Call August 14, 2023 5:00 PM ET Company Participants Rajiv De Silva – Chief Executive Officer Hemanth Varghese – President and Chief Innovation and Business Officer Domenic Della Penna – Chief Financial Officer Conference Call Participants Jeff Cohen – Ladenburg Thalmann Marie Thibault – BTIG Anthony Vendetti – Maxim Group Operator Good day, ladies and gentlemen. Welcome to the Second Quarter 2023 Earnings Conference Call for Venus Concept.

04:05 20 Feb 2024 VERO

Venus Concept to Release Second Quarter of Fiscal Year 2023 Financial Results on August 14, 2023

TORONTO, July 05, 2023 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that second quarter of fiscal year 2023 financial results will be released after the market closes on Monday, August 14, 2023.

10:07 20 Feb 2024 VERO

Venus Concept Inc. (VERO) Q1 2023 Earnings Call Transcript

Venus Concept Inc. (NASDAQ:VERO ) Q1 2023 Earnings Conference Call May 15, 2023 8:00 AM ET Company Participants Rajiv De Silva - CEO Hemanth Varghese - President & Chief Innovation and Business Officer Domenic Della Penna - CFO Conference Call Participants Destiny Hance - Ladenburg Thalmann Operator Good day, ladies and gentlemen, and welcome to the First Quarter 2023 Earnings Conference Call for Venus Concept Inc. At this time, all participants have been placed in a listen-only mode. Please note that this conference call is being recorded and that the recording will be available on the company's website for replay.

07:30 20 Feb 2024 VERO

Venus Concept to Release First Quarter of Fiscal Year 2023 Financial Results on May 15, 2023

TORONTO, April 11, 2023 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that first quarter of fiscal year 2023 financial results will be released before the market opens on Monday, May 15, 2023.

01:11 20 Feb 2024 VERO

Venus Concept Inc. (VERO) Q4 2022 Earnings Call Transcript

Venus Concept Inc. (NASDAQ:VERO ) Q4 2022 Earnings Conference Call March 27, 2023 8:00 AM ET Company Participants Rajiv De Silva - Chief Executive Officer Hemanth Varghese - President and Chief Innovation and Business Officer Domenic Della Penna - Chief Financial Officer Conference Call Participants Marie Thibault - BTIG Anthony Vendetti - Maxim Group Jeffrey Cohen - Ladenburg Thalmann Operator Good day ladies and gentlemen and welcome to the Fourth Quarter 2022 Earnings Conference Call for Venus Concept Inc. At this time, all participants have been placed in a listen-only mode. Please note that this conference call is being recorded and that the recording will be available on the company's website for replay.

06:00 20 Feb 2024 VERO

Trading Penny Stocks? Top Technical Analysis Tips

Can this help you to make money with penny stocks? The post Trading Penny Stocks?

10:10 20 Feb 2024 VERO

Why Is Venus Concept (VERO) Stock Up 81% Today?

Venus Concept (NASDAQ: VERO ) stock is rocketing higher on Wednesday following approval for its fractional skin resurfacing technology. The U.S. Food and Drug Administration (FDA) has signed off on the company's surgical robotic technology platform called AI.ME.

VERO Financial details

Company Rating
Neutral
Market Cap
6.19M
Income
-36.04M
Revenue
82.51M
Book val./share
-2.2
Cash/share
0.89
Dividend
-
Dividend %
-
Employees
384
Optionable
No
Shortable
Yes
Earnings
25 Mar 2024
P/E
-0.24
Forward P/E
-0.73
PEG
0.13
P/S
0.11
P/B
-0.72
P/C
1.34
P/FCF
-0.56
Quick Ratio
1.58
Current Ratio
2.76
Debt / Equity
-6.89
LT Debt / Equity
-7.24
-
-
EPS (TTM)
-4.97
EPS next Y
-1.64
EPS next Q
1.58
EPS this Y
-89.18%
EPS next Y
-67.1%
EPS next 5Y
-67.1%
EPS last 5Y
-67.87%
Revenue last 5Y
35.29%
Revenue Q/Q
-12.25%
EPS Q/Q
21.48%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-50%
Inst Own
21.08%
Inst Trans
0.03%
ROA
-36%
ROE
1289%
ROC
-0.41%
Gross Margin
68%
Oper. Margin
-36%
Profit Margin
-44%
Payout
-
Shs Outstand
5.53M
Shs Float
3.25M
-
-
-
-
Target Price
5.5
52W Range
0.874-4.7
52W High
-
52W Low
-
RSI
43
Rel Volume
0.33
Avg Volume
12.78K
Volume
4.23K
Perf Week
-3.7%
Perf Month
-19.59%
Perf Quarter
-30.17%
Perf Half Y
-37.15%
-
-
-
-
Beta
0.684
-
-
Volatility
0.04%, 0.1%
Prev Close
6.62%
Price
1.1941
Change
3.39%

VERO Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
147.41194.4531.9529.0922.63
Net income per share
-192.87-74.49-33.92-6.1-9.91
Operating cash flow per share
-192.68-69.73-11.73-5.44-6.14
Free cash flow per share
-199.44-71.71-11.85-5.59-6.21
Cash per share
108.2427.5914.058.52.63
Book value per share
10.62130.6418.1211.281.84
Tangible book value per share
10.6247.3610.27.22-0.72
Share holders equity per share
10.62130.6418.1211.281.84
Interest debt per share
145.63134.8536.0222.8120.09
Market cap
14.61M40.03M63.36M92.59M21.11M
Enterprise value
17.96M93.38M108.67M139.58M93.3M
P/E ratio
-0.51-0.95-0.77-4.18-0.48
Price to sales ratio
0.670.360.810.880.21
POCF ratio
-0.51-1.01-2.21-4.68-0.78
PFCF ratio
-0.49-0.98-2.19-4.57-0.77
P/B Ratio
9.240.541.432.262.61
PTB ratio
9.240.541.432.262.61
EV to sales
0.820.851.391.320.94
Enterprise value over EBITDA
-0.68-4.6-2.69-7.96-3.07
EV to operating cash flow
-0.63-2.36-3.79-7.06-3.46
EV to free cash flow
-0.6-2.29-3.75-6.88-3.42
Earnings yield
-1.97-1.06-1.31-0.24-2.06
Free cash flow yield
-2.03-1.02-0.46-0.22-1.29
Debt to equity
12.310.931.81.910.35
Debt to assets
0.630.360.50.510.67
Net debt to EBITDA
-0.13-2.63-1.12-2.68-2.37
Current ratio
3.142.073.553.432.12
Interest coverage
-11.65-2.69-4.85-3.54-7.65
Income quality
10.940.350.890.62
Dividend Yield
000.0600
Payout ratio
00-0.0400
Sales general and administrative to revenue
0.40.430.740.430.5
Research and developement to revenue
0.380.070.10.080.11
Intangibles to total assets
00.260.120.10.1
Capex to operating cash flow
0.040.030.010.030.01
Capex to revenue
-0.05-0.01000
Capex to depreciation
-1.24-0.55-0.06-0.11-0.08
Stock based compensation to revenue
0.030.020.030.020.02
Graham number
214.69467.93117.5839.3320.26
ROIC
-1.23-0.15-0.33-0.14-0.35
Return on tangible assets
-0.93-0.3-0.58-0.16-0.38
Graham Net
-37.47-79.48-13.93-9.9-14.82
Working capital
20.11M51.53M82.89M75.78M44.41M
Tangible asset value
1.58M26.89M24.9M26.2M-3.18M
Net current asset value
100K-14.75M-1.36M-5.28M-32.63M
Invested capital
12.310.931.81.910.35
Average receivables
5.22M32.77M55.87M49.84M42.09M
Average payables
2.93M6.61M7.86M5.62M6.47M
Average inventory
4.14M12.18M18.3M19.15M22.22M
Days sales outstanding
109.2194.98246.86162.14136.69
Days payables outstanding
111.85101.6686.6756.8887.46
Days of inventory on hand
161.89203.78243.48237.83260.27
Receivables turnover
3.341.871.482.252.67
Payables turnover
3.263.594.216.424.17
Inventory turnover
2.251.791.51.531.4
ROE
-18.16-0.57-1.87-0.54-5.39
Capex per share
-6.75-1.98-0.12-0.14-0.08

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
4.955.173.933.673.19
Net income per share
-3.33-2.12-1.84-1.35-1.64
Operating cash flow per share
-0.89-0.73-1.13-0.39-0.74
Free cash flow per share
-0.9-0.73-1.14-0.39-0.74
Cash per share
1.562.461.231.120.89
Book value per share
2.151.72-0.17-1.14-2.2
Tangible book value per share
-0.64-0.68-2.16-2.88-3.75
Share holders equity per share
2.151.72-0.17-1.14-2.2
Interest debt per share
18.1218.1416.2815.5715.46
Market cap
28.72M22.53M17.17M11.49M10.83M
Enterprise value
99.56M94.73M94.19M89.02M89.77M
P/E ratio
-0.5-0.57-0.45-0.39-0.3
Price to sales ratio
1.330.930.840.570.61
POCF ratio
-7.44-6.61-2.92-5.41-2.66
PFCF ratio
-7.35-6.54-2.88-5.36-2.66
P/B Ratio
3.072.78-19.38-1.85-0.89
PTB ratio
3.072.78-19.38-1.85-0.89
EV to sales
4.623.94.594.435.1
Enterprise value over EBITDA
-9.62-10.66-13.18-18.81-15.61
EV to operating cash flow
-25.79-27.8-16-41.95-22.03
EV to free cash flow
-25.49-27.49-15.81-41.52-22.05
Earnings yield
-0.5-0.44-0.56-0.64-0.84
Free cash flow yield
-0.14-0.15-0.35-0.19-0.38
Debt to equity
8.3110.35-94.17-13.45-6.89
Debt to assets
0.640.670.740.790.85
Net debt to EBITDA
-6.85-8.12-10.77-16.38-13.72
Current ratio
2.742.122.152.172.76
Interest coverage
-9.37-6.42-5.41-3.71-4.21
Income quality
0.270.340.610.290.46
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.660.530.540.480.57
Research and developement to revenue
0.120.110.130.10.11
Intangibles to total assets
0.110.10.10.10.09
Capex to operating cash flow
0.010.010.010.010
Capex to revenue
00000
Capex to depreciation
-0.04-0.03-0.07-0.020
Stock based compensation to revenue
0.030.020.020.020.02
Graham number
12.699.062.655.899.02
ROIC
-0.13-0.08-0.09-0.07-0.09
Return on tangible assets
-0.13-0.09-0.09-0.08-0.1
Graham Net
-13.7-13.89-12.63-12.06-12.06
Working capital
51.25M44.41M41.54M40.85M45.77M
Tangible asset value
-2.78M-3.18M-11.27M-15.74M-20.7M
Net current asset value
-29.85M-32.63M-35.27M-35.91M-38.53M
Invested capital
8.3110.35-94.17-13.45-6.89
Average receivables
46.2M40.04M38.2M38.33M36.77M
Average payables
5.14M7.06M7.77M7.9M7.71M
Average inventory
23.3M24.07M23.29M22.8M23.16M
Days sales outstanding
178.87138.09171.61168.21184.06
Days payables outstanding
67.1585.0998.94127.48117.99
Days of inventory on hand
267.17253.21298.68352.56387.64
Receivables turnover
0.50.650.520.540.49
Payables turnover
1.341.060.910.710.76
Inventory turnover
0.340.360.30.260.23
ROE
-1.55-1.2310.861.190.75
Capex per share
-0.01-0.01-0.0100

VERO Frequently Asked Questions

What is Venus Concept Inc. stock symbol ?

Venus Concept Inc. is a CA stock , located in Toronto of On and trading under the symbol VERO

What is Venus Concept Inc. stock quote today ?

Venus Concept Inc. stock price is $1.1941 today.

Is Venus Concept Inc. stock public?

Yes, Venus Concept Inc. is a publicly traded company.

Something similar

Top by Market Cap
Same Sector
Top Correlated Stocks
Similar Market Cap